DMC Biotechnologies completes downstream processing for L-alanine

The purification of L-alanine from the fermentation broth was completed for more than 6,000 kg of product

Catalent acquires third facility in Belgium for pDNA manufacturing

CDMO Catalent has acquired liver disease specialist Promethera's cell therapy manufacturing subsidiary, including its ...

BioVaxys and BioElpida agree to begin ovarian cancer vaccine bioproduction

The two companies have signed the new definitive agreement focusing on the GMP facility build-out in Lyon, and ...

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part III)

Dr Kevin Robinson held a virtual roundtable with representatives from a number of top-tier contract (development and) ...

German CDMO to spend $84m expanding biological cGMP space

Richter-Helm BioLogics has received investment for the new multi-product biological manufacturing facility that is ...

Lonza to double drug substance production for Moderna vaccine

In May 2020, the companies announced a 10-year agreement to enable the manufacture of the COVID-19 vaccine and ...

Asher contracts ProBioGen to develop lead candidate

ProBioGen will now advance the development of Asher's lead candidate in immuno-oncology, applying its transposase ...

AavantiBio and Catalent announce partnership

Catalent will support the development and manufacturing of AavantiBio’s gene therapies for rare genetic diseases

The CMO RFQ process and expectation management

Managing expectations during a request for quotation (RFQ) process is a crucial part of establishing a trustful and ...

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part II)

Dr Kevin Robinson held a virtual roundtable with representatives from a number of top-tier contract (development and) ...

DNA Script Partners with Moderna

The partnership will develop a prototype for the on-demand manufacturing of caccines and therapeutics for DARPA

Evonik delivers first lipids from German facility to BioNTech

The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle

Advanced catalysts for biomass transformation

OEM instruments for secure sample tracking

SGD introduces Type 1 molded glass vials to portfolio

AMRI provides excipient manufacturing services for Pfizer-BioNTech

Coripharma appoint Senior Business Development Manager

Eurofins CDMO – helping you advance your programs with speed and confidence

CDMO Piramal agrees sterile fill/finish programme with Theratechnologies

CS Analytical Laboratory names new Director of Quality

Michael Smith Engineers introduces low flow high pressure pumps

Aldevron launches CRISPR RNP manufacturing service

Fast track vaccines to market

Moderna and Catalent manufacture Moderna's COVID-19 vaccine candidate

Idifarma enlists consultant for spray drying and particle engineering

Biotech chooses PolyPeptide Group for vaccine adjuvant intermediates

Sterling Pharma Solutions commences production of potential COVID-19 treatment

Catalent announces collaboration with Johnson & Johnson